type here...

CATEGORIES

Blood Conditions

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Travel? Don’t Forget This.

Michael Hunter, MD -
HERE’S ME: IPAD TO WATCH FILMS? CHECK. Kindle for reading books and the New York Times? Again, check. Chargers for all my gear. Got it....

Can We Dare to Think about an End to AIDS?

Mark Chataway -
What would my 23-year-old self have made of my 63-year-old self moderating a session on the end of AIDS as a public health threat...

The Remarkable Research Of CAR T Therapy: B Cell Cancers

William Haseltine, PhD -
The first installment lays the foundation for understanding how CAR T works. This second piece delves into the use of CAR T to treat B cell cancers.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories